Indeed, VSNL1 overexpression was associated with a higher risk of lymphatic invasion and a poorer prognosis in a series of patients with early stage CRC [30], and downregulation of this gene was observed in camptothecin-resistant gastric cancer cell lines [29]. The gene discussed is VSNL1; the disease is colorectal carcinoma.